|
|
||||||||
Regular Article |
Received January 27, 1997; revised May 13, 1997; accepted June 26, 1997. From the Mental Health Clinical Research Center for the Study of Late-Life Mood Disorders (MHCRC/LLMD), Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania. Address correspondence to Dr. Reynolds, Mental Health Clinical Research Center for the Study of Late-Life Mood Disorders (MHCRC/LLMD), Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, PA 15213.
ECGs of 50 patients who completed a long-term nortriptyline (NT) study are presented at baseline, after 7 weeks on NT, and after 1 year. The ECGs of patients with preexisting cardiac disease were compared with non-cardiac patients. Significant ECG changes and increases in heart rate were observed by Week 7 and persisted at a mean of 55 weeks (range: 24111) in patients who were continued on NT. No significant difference was found in long-term ECG effects in patients with preexisting cardiac disease; ECG changes reverted to baseline when placebo was substituted. Patients with known cardiac disease did not show significantly worse ECG changes on NT than non-cardiac patients.
Key Words: Geriatric Depression ECG Changes Nortriptyline
This article has been cited by other articles:
![]() |
E. M. Johnson, E. Whyte, B. H. Mulsant, B. G. Pollock, E. Weber, A. E. Begley, and C. F. Reynolds Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression Am J Geriatr Psychiatry, September 1, 2006; 14(9): 796 - 802. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |